About this Event
Jo is a seasoned biotech executive and entrepreneurial scientist who has taken more than a dozen drugs to clinic over her 30-year career.
Prior to founding Seismic, she founded Pandion Therapeutics in 2017 and served as President and Chief Scientific Officer until the acquisition by Merck for $1.85B in 2021. Prior to Pandion, she held research leadership positions at Biogen, Amgen and Immunex. She is an experienced director on both private and public company boards.
In 2024 she was recognized as a Distinguished Fellow by the American Association for Immunologists. In 2022 she was named as one of the Extraordinary Women Advancing Healthcare in Massachusetts by The Women’s Edge, and she was profiled in the Boston Business Journal’s Women to Watch. Jo has also featured in FiercePharma’s 2020 Fiercest Women in Life Sciences and in Endpoints’ 2019 Special Report on 20 Extraordinary Women.
Jo is an advocate for workplace inclusiveness and regularly volunteers her time with organizations focused on increasing diversity. She has served on the board of WEST, a non-profit organization supporting early to mid-career women, including as President 2017-18.
Jo has a PhD in immunology from the University of London, and a BSc (Hons) in biophysics from the University of East London.
Event Venue
Rajen Kilachand Center for Integrated Life Sciences and Engineering, 610 Commonwealth Avenue, Boston, United States
